Literature DB >> 8354918

Kinetics of specific IgG antibodies for monitoring the effect of anti-Helicobacter pylori chemotherapy.

A M Hirschl1, G Brandstätter, B Dragosics, E Hentschel, M Kundi, M L Rotter, K Schütze, M Taufer.   

Abstract

A total of 104 patients with recurrent duodenal ulcer were treated with either ranitidine plus amoxicillin plus metronidazole or ranitidine plus placebo. To study the effect of the eradication of Helicobacter pylori on the systemic immune response in an IgG ELISA, sera were drawn from all patients before the onset of therapy and at 6, 16 +/- 2, 32 +/- 2, and 60 +/- 2 weeks after therapy. In patients with eradication of the organism, a significant (P < .001) reduction of the specific IgG titer occurred. This was not observed in patients without bacterial eradication. If a titer reduction of > 50% was taken as an indicator for eradication of H. pylori, the sensitivity of the serologic test was 97.6%-99.7%. Its specificity increased with the interval to the onset of chemotherapy from 56.3% to 97.6%. Serologic tests are simple to perform and cause very little discomfort to the patient.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8354918     DOI: 10.1093/infdis/168.3.763

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  14 in total

Review 1.  Naturally acquired human immune responses against Helicobacter pylori and implications for vaccine development.

Authors:  Y Zevering; L Jacob; T F Meyer
Journal:  Gut       Date:  1999-09       Impact factor: 23.059

2.  A follow-up study on the effect of Helicobacter pylori eradication on the severity of gastric histology.

Authors:  Barik A Salih; M Fatih Abasiyanik; Huseyin Saribasak; Osman Huten; Ersan Sander
Journal:  Dig Dis Sci       Date:  2005-08       Impact factor: 3.199

3.  Evaluation of enzyme immunoassay for detection of salivary antibody to Helicobacter pylori.

Authors:  A E Simor; E Lin; F Saibil; L Cohen; M Louie; S Pearen; H A Donhoffer
Journal:  J Clin Microbiol       Date:  1996-03       Impact factor: 5.948

Review 4.  Diagnosis of Helicobacter pylori.

Authors:  U Blecker; D I Mehta
Journal:  Indian J Pediatr       Date:  1997 Nov-Dec       Impact factor: 1.967

5.  Prevalence of Helicobacter pylori in United States Navy submarine crews.

Authors:  R P Jackman; C Schlichting; W Carr; A Dubois
Journal:  Epidemiol Infect       Date:  2005-09-30       Impact factor: 2.451

6.  Does the antibody production ability affect the serum anti-Helicobacter pylori IgG titer?

Authors:  Hyun Ah Chung; Sun-Young Lee; Hee Won Moon; Jeong Hwan Kim; In-Kyung Sung; Hyung Seok Park; Chan Sup Shim; Hye Seung Han
Journal:  World J Gastrointest Pathophysiol       Date:  2016-08-15

7.  Positive result by serology indicates active Helicobacter pylori infection in patients with atrophic gastritis.

Authors:  A Kokkola; H Rautelin; P Puolakkainen; P Sipponen; M Färkkilä; R Haapiainen; T U Kosunen
Journal:  J Clin Microbiol       Date:  1998-06       Impact factor: 5.948

8.  Comparison of different criteria for interpretation of immunoglobulin G immunoblotting results for diagnosis of Helicobacter pylori infection.

Authors:  Philipp M Lepper; Angelika Möricke; Konstanze Vogt; Günter Bode; Matthias Trautmann
Journal:  Clin Diagn Lab Immunol       Date:  2004-05

9.  Serological assessment of the early response to eradication therapy using an immunodominant outer membrane protein of Helicobacter pylori.

Authors:  A Nishizono; T Gotoh; T Fujioka; K Murakami; T Kubota; M Nasu; M Watanabe; K Mifune
Journal:  Clin Diagn Lab Immunol       Date:  1998-11

10.  Evaluation of a new immunodiagnostic assay for Helicobacter pylori antibody detection: correlation with histopathological and microbiological results.

Authors:  A D Pronovost; S L Rose; J W Pawlak; H Robin; R Schneider
Journal:  J Clin Microbiol       Date:  1994-01       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.